Literature DB >> 17540814

Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.

David H Barad1, Andrea Weghofer, Norbert Gleicher.   

Abstract

OBJECTIVE: Traditionally, the most important measurement in the assessment of ovarian function has been age-independent baseline follicle-stimulating hormone (FSH) levels. The objective of this study was to characterize the continuum of ovarian function based on age-specific categories of baseline FSH.
METHODS: In a cross-sectional historical cohort study we evaluated records of 434 patients with baseline FSH levels of less than 12 milli international units/mL that underwent ovulation induction for in vitro fertilization (IVF) with long gonadotropin-releasing hormone (GnRH) antagonist or GnRH agonist suppression and modal gonadotropin stimulation of 300 units of gonadotropins per day. In these patients with apparent normal ovarian function by current baseline FSH criteria and with routine ovarian stimulation, we assessed IVF cycle outcomes, including oocyte yields, based on age-specific baseline FSH levels, defined as levels less than or equal to the 95% confidence interval for each age group.
RESULTS: Age-specific baseline FSH levels predicted the retrieval of fewer than or equal to four oocytes, with a positive predictive value of 19.5% and a negative predictive value of 88%. The Mantel-Haenszel common odds ratio for fewer than or equal to 4 oocyte production in the presence of premature ovarian aging was 2.8 (95% confidence interval 1.52-5.17; P<.001).
CONCLUSION: These results suggest that, within generally accepted normal baseline FSH values, women with baseline FSH above the 95% confidence limits for age produce fewer oocytes in response to normal ovulation induction protocols compared with other women their age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540814     DOI: 10.1097/01.AOG.0000264065.37661.a0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  31 in total

1.  More on the conversion of DHEA to testosterone.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly A Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-07-14       Impact factor: 43.330

2.  Comparison of ovarian FMR1 genotypes and sub-genotypes in oocyte donors and infertile women.

Authors:  Norbert Gleicher; Andrea Weghofer; Ann Kim; David H Barad
Journal:  J Assist Reprod Genet       Date:  2012-03-17       Impact factor: 3.412

3.  How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.

Authors:  Norbert Gleicher; Sarah K Darmon; Vitaly A Kushnir; Andrea Weghofer; Qi Wang; Lin Zhang; David F Albertini; David H Barad
Journal:  Endocrine       Date:  2016-08-10       Impact factor: 3.633

Review 4.  A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice.

Authors:  Norbert Gleicher; David H Barad
Journal:  J Assist Reprod Genet       Date:  2012-10-05       Impact factor: 3.412

Review 5.  Medical Genetics for Practicing Obstetrician.

Authors:  K N Sreelakshmi
Journal:  J Obstet Gynaecol India       Date:  2019-08-28

Review 6.  Dehydroepiandrosterone: A panacea for the ageing ovary?

Authors:  Nikita Naredi; K Sandeep; V D S Jamwal; N Nagraj; Seema Rai
Journal:  Med J Armed Forces India       Date:  2015-02-25

7.  Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2010-06-17       Impact factor: 5.211

8.  Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS).

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2010-11-10       Impact factor: 5.211

9.  Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

Authors:  Norbert Gleicher; Ann Kim; Andrea Weghofer; Aya Shohat-Tal; Emanuela Lazzaroni; Ho-Joon Lee; David H Barad
Journal:  J Assist Reprod Genet       Date:  2012-12-05       Impact factor: 3.412

10.  Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.

Authors:  Norbert Gleicher; Eddy Ryan; Andrea Weghofer; Sonia Blanco-Mejia; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2009-10-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.